ACTRN12613000194763
Not yet recruiting
未知
A pilot study of the utility of combination F18-fluorodeoxyglucose and F18-fluorocholine positron emission tomography imaging in diagnostics, prognosis and treatment response prediction in newly diagnosed hepatocellular carcinoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hepatocellular carcinoma (HCC)
- Sponsor
- Department of Nuclear Medicine
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed HCC
- •Barcelona\-Clinic Liver Cancer Stage O, A or B
- •Considered for transarterial chemoembolisation, radiofrequency ablation or resection
Exclusion Criteria
- •Previously diagnosed benign or malignant lesions of the liver including HCC
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical study to evaluate the usefulness of 18F-FBPA-PET for patient selection and expanding indication for BNCTHead and Neck Cancer,Malignant gliomaJPRN-UMIN000035976Southern TOHOKU BNCT Research Center20
Active, not recruiting
Phase 1
A Pilot Study Investigating the Sensitivity of 18F-labelled Sodium Fluoride PET-CT for Detecting Skeletal Metastases in Renal Cell Carcinoma compared to Planar Bone Scintigraphy and Multidetector CT - 18F-Fluoride PET-CT for Detecting Bone Metastases in RCCEUCTR2010-024624-20-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge
Active, not recruiting
Phase 1
Experimental study to evaluate the effect of PET/TC using 18F-PSMA label in the management of patients with prostate cancer.Prostate cancerMedDRA version: 20.0Level: LLTClassification code 10029002Term: Neoplasm of the prostateSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2019-002000-41-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS500
Active, not recruiting
Not Applicable
A phase II Feasibility Study on the use of 18Fluoro-L-Thymidine and Positron Emission Tomography (FLT-PET) on Prognosis and Staging in Patients with Locoregionally Advanced Mucosal Head and Neck Squamous Cell CarcinomaHead and Neck CancerCancer - Head and neckACTRN12613000205730Royal Brisbane and Women's Hospital10
Completed
Not Applicable
A study of usefulness of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the initial staging and assessment of response to treatment in locally advanced breast cancerHealth Condition 1: null- patients with locally advanced breast cancerCTRI/2018/04/013455Sri Venkateswara Institute of Medical Sciences